FY2025 EPS Estimates for DNTH Increased by Cantor Fitzgerald
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Cantor Fitzgerald lifted their FY2025 EPS estimates for Dianthus Therapeutics in a research report issued on Thursday, March 13th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will earn ($3.16) per share for the year, up from their previous estimate of ($3.46). The consensus estimate […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Cantor Fitzgerald lifted their FY2025 EPS estimates for Dianthus Therapeutics in a research report issued on Thursday, March 13th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the company will earn ($3.16) per share for the year, up from their previous estimate of ($3.46). The consensus estimate […]
